Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen

7680689200019 CH-68920 Tabletten zur Herstellung einer Suspension zum Einnehmen
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Tabletten zur Herstellung einer Suspension zum Einnehmen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/09/2025
Patient information leaflet
Français
26/09/2025
Patient information leaflet
Italien
26/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
0.9 MG Substance HBESI

Authorization holder

ViiV Healthcare GmbH

6340 Baar

Authorization information

Swissmedic authorization number
68920
Drug name
Triumeq, Tabletten zur Herstellung einer Suspension zum Einnehmen
Galenic form
TAB
ATC Code
J05AR13
Authorization status
Z
Dispensing category
A
First authorization
24/08/2023
Authorization expiration date
23/08/2028
IT Number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Package details

Description (FR)
TRIUMEQ cpr disp 5mg/60mg/30mg bte 90 pce
Description (DE)
TRIUMEQ Disp Tabl 5mg/60mg/30mg Ds 90 Stk
Market launch
24/08/2023
Narcotic (BTM)
No